Wolf Plínio José Whitaker, Finger Marco Aurelio, Rossi Neto João Manoel, Santos Carolina Casadei, Mattos Victor Bemfica de Mello, Rossi Raphael, Damiani Lucas Petri
Instituto Dante Pazzanese de Cardiologia, São Paulo, SP - Brasil.
Hospital Israelita Albert Einstein - ARO, São Paulo, SP - Brasil.
Arq Bras Cardiol. 2024 Jun;121(6):e20230588. doi: 10.36660/abc.20230588.
It is unknown whether lymphopenia is a risk factor for the reactivation of Chagas disease in heart transplantation (HTx), as recently described in the reactivation of cytomegalovirus in transplant patients.
To evaluate whether lymphopenia in the perioperative period of heart transplantation is related to early Trypanosoma cruzi parasitemia.
This observational, retrospective study analyzed a sample from January 2014 to January 2023). Parasitemia was evaluated in the first 3 months after HTx using serum polymerase chain reaction (PCR) and compared with the total lymphocyte count in the perioperative period of HTx using receiver operating characteristic curves. Baseline characteristics were compared with PCR for Chagas using independent Cox proportional hazards models. A significance level of 5% was adopted.
The sample (n = 35) had a mean age of 52.5 ± 8.1 years, and 22 patients (62.8%) had positive PCR for Chagas. The mean lowest lymphocyte values in the first 14 days after HTx were 398 ± 189 and 755 ± 303 cells/mm3 in patients with and without parasitemia, respectively, within 3 months after HTx (area under the curve = 0.857; 95% confidence interval: 0.996 to 0.718, sensitivity and specificity of 83.3% and 86.4%). A cutoff value of less than 550 lymphocytes/mm3 was determined as a risk factor for the presence of parasitemia. Patients with lymphocytes < 550 units/mm3 in the first 14 days after HTx presented positive PCR in 80% of cases. For every increase of 100 lymphocytes/mm3, the risk of PCR positivity was reduced by 26% (hazard rate ratio = 0.74; 95% confidence interval: 0.59 to 0.93, p = 0.009).
There was an association between lymphopenia in the perioperative period of HTx and early T. cruzi parasitemia detected by PCR.
目前尚不清楚淋巴细胞减少是否是心脏移植(HTx)中恰加斯病再激活的危险因素,就像最近在移植患者中发现的巨细胞病毒再激活情况一样。
评估心脏移植围手术期的淋巴细胞减少是否与早期克氏锥虫血症有关。
这项观察性回顾性研究分析了2014年1月至2023年1月的样本。在心脏移植后的前3个月,使用血清聚合酶链反应(PCR)评估寄生虫血症,并使用受试者工作特征曲线将其与心脏移植围手术期的总淋巴细胞计数进行比较。使用独立的Cox比例风险模型将基线特征与查加斯病PCR结果进行比较。采用5%的显著性水平。
样本(n = 35)的平均年龄为52.5±8.1岁,22名患者(62.8%)查加斯病PCR呈阳性。心脏移植后前14天淋巴细胞的平均最低值在移植后3个月内,有寄生虫血症和无寄生虫血症的患者分别为398±189和755±303个细胞/mm³(曲线下面积 = 0.857;95%置信区间:0.996至0.718,敏感性和特异性分别为83.3%和86.4%)。确定淋巴细胞计数低于550个/mm³为存在寄生虫血症的危险因素。心脏移植后前14天淋巴细胞<550个单位/mm³的患者中,80%的病例PCR呈阳性。淋巴细胞每增加100个/mm³,PCR阳性风险降低26%(风险率比 = 0.74;95%置信区间:0.59至0.93,p = 0.009)。
心脏移植围手术期的淋巴细胞减少与PCR检测到的早期克氏锥虫血症之间存在关联。